Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wietske Kievit

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
The Journal of Rheumatology|March 2, 2021
If You Want to Perform a Cost-effectiveness Trial, First Do a Modeling StudyWietske Kievit, Alfons A den Broeder
International Journal of Technology Assessment in Health Care|May 7, 2026
Competencies for Health Technology Assessment Professionals: A Scoping Review and Content AnalysisLiza van Mun, Wietske Kievit, Wija Oortwijn
International Journal of Technology Assessment in Health Care|November 9, 2017
THE ADDED VALUE OF INTEGRATE-HTA GUIDANCE IN THE WORK PROCESSES OF HEALTH TECHNOLOGY ASSESSMENT AGENCIESGert Jan van der Wilt, Wietske Kievit, Wija Oortwijn
Drugs & Aging|August 19, 2009
Tumour necrosis factor-alpha antagonists in the management of rheumatoid arthritis in the elderly: a review of their efficacy and safetyBeáta J Radovits, Wietske Kievit, Roland F J M Laan
International Journal of Technology Assessment in Health Care|December 17, 2025
Building sustainable health technology assessment capacity in UkraineWija Oortwijn, Jip Janssen, Olena Filiniuk, et al.
Arthritis Care & Research|June 11, 2010
Factors that influence rheumatologists' decisions to escalate care in rheumatoid arthritis: results from a choice-based conjoint analysisWietske Kievit, Laura van Hulst, Piet van Riel, et al.
British Journal of Clinical Pharmacology|May 22, 2019
Optimizing the dose in patients treated with imatinib as first line treatment for gastrointestinal stromal tumours: A cost-effectiveness studySander Zuidema, Ingrid M E Desar, Nielka P van Erp, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 26, 2014
Individual patient monitoring in daily clinical practice: a critical evaluation of minimal important changeJos Hendrikx, Jaap Fransen, Wietske Kievit, et al.
Rheumatology (Oxford, England)|March 25, 2016
The influence of patient perceptions of disease on medication intensification in daily practiceJos Hendrikx, Wietske Kievit, Jaap Fransen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 30, 2026
A Competency Framework for Health Technology Assessment Expertise: Results from a Delphi StudyLiza A M van Mun, Wietske Kievit, Debjani Mueller, et al.
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
The Journal of Rheumatology|March 2, 2021
If You Want to Perform a Cost-effectiveness Trial, First Do a Modeling StudyWietske Kievit, Alfons A den Broeder
International Journal of Technology Assessment in Health Care|May 7, 2026
Competencies for Health Technology Assessment Professionals: A Scoping Review and Content AnalysisLiza van Mun, Wietske Kievit, Wija Oortwijn
International Journal of Technology Assessment in Health Care|November 9, 2017
THE ADDED VALUE OF INTEGRATE-HTA GUIDANCE IN THE WORK PROCESSES OF HEALTH TECHNOLOGY ASSESSMENT AGENCIESGert Jan van der Wilt, Wietske Kievit, Wija Oortwijn
Drugs & Aging|August 19, 2009
Tumour necrosis factor-alpha antagonists in the management of rheumatoid arthritis in the elderly: a review of their efficacy and safetyBeáta J Radovits, Wietske Kievit, Roland F J M Laan
International Journal of Technology Assessment in Health Care|December 17, 2025
Building sustainable health technology assessment capacity in UkraineWija Oortwijn, Jip Janssen, Olena Filiniuk, et al.
Arthritis Care & Research|June 11, 2010
Factors that influence rheumatologists' decisions to escalate care in rheumatoid arthritis: results from a choice-based conjoint analysisWietske Kievit, Laura van Hulst, Piet van Riel, et al.
British Journal of Clinical Pharmacology|May 22, 2019
Optimizing the dose in patients treated with imatinib as first line treatment for gastrointestinal stromal tumours: A cost-effectiveness studySander Zuidema, Ingrid M E Desar, Nielka P van Erp, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 26, 2014
Individual patient monitoring in daily clinical practice: a critical evaluation of minimal important changeJos Hendrikx, Jaap Fransen, Wietske Kievit, et al.
Rheumatology (Oxford, England)|March 25, 2016
The influence of patient perceptions of disease on medication intensification in daily practiceJos Hendrikx, Wietske Kievit, Jaap Fransen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 30, 2026
A Competency Framework for Health Technology Assessment Expertise: Results from a Delphi StudyLiza A M van Mun, Wietske Kievit, Debjani Mueller, et al.
Pageof 16